InBios International
Bob Hammond is an experienced professional in the field of regulatory compliance, currently serving as the Controlled Substance Manager at Janssen La Jolla Research and Development since October 2022. Hammond has been with Johnson & Johnson since 2012 and has held various roles at ALZA Corporation since 1999, including Senior Compliance Specialist and Manager of DEA Compliance. Additionally, Hammond worked as a DEA Compliance Specialist for Janssen Pharmaceutical from August 2017 to November 2022. Education includes a Bachelor of Arts in Management from Saint Mary's College of California and an Associate of Arts in Air Transportation from the Community College of the Air Force, along with studies in Management at the University of Maryland extension campus.
This person is not in the org chart
This person is not in any offices
InBios International
InBios is a leading biotechnology company based in Seattle, Washington (USA). At InBios, we believe an accurate diagnosis is the first step to effective treatment. Specializing in the design, development and manufacture of immunodiagnostic devices for infectious diseases and biothreats, we strive to improve health outcomes globally by providing superior quality products that are accurate, easy to use and cost effective.